BG66625B1 - Антитуморно лекарство, метод за получаването му и метод за стабилизирането му - Google Patents

Антитуморно лекарство, метод за получаването му и метод за стабилизирането му Download PDF

Info

Publication number
BG66625B1
BG66625B1 BG110926A BG11092611A BG66625B1 BG 66625 B1 BG66625 B1 BG 66625B1 BG 110926 A BG110926 A BG 110926A BG 11092611 A BG11092611 A BG 11092611A BG 66625 B1 BG66625 B1 BG 66625B1
Authority
BG
Bulgaria
Prior art keywords
dna
solution
fluorouracil
drug
urea
Prior art date
Application number
BG110926A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG110926A (bg
Inventor
Олег СОКИРКО
Сергеевич Сокирко Олег
Илима ВОЛЧЕНСКОВА
Илиодоровна Волченскова Киев Илима
Надежда МАЙДАНЕВИЧ
Николаевна Майданевич Вишневое Надежда (UA)
Original Assignee
Сергеевич Сокирко Олег
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from UAA200906849A external-priority patent/UA90233C2/uk
Application filed by Сергеевич Сокирко Олег filed Critical Сергеевич Сокирко Олег
Publication of BG110926A publication Critical patent/BG110926A/bg
Publication of BG66625B1 publication Critical patent/BG66625B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG110926A 2008-12-22 2009-11-23 Антитуморно лекарство, метод за получаването му и метод за стабилизирането му BG66625B1 (bg)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
UA200814666 2008-12-22
UAA200814666 2008-12-22
UAA200906849 2009-06-30
UAA200906849A UA90233C2 (uk) 2009-06-30 2009-06-30 Спосіб стабілізації протипухлинних засобів на основі водного розчину сполуки платини з дезоксирибонуклеїновою кислотою
PCT/UA2009/000058 WO2010074662A1 (ru) 2008-12-22 2009-11-23 Противоопухолевое средство, способ его получения и способ его стабилизации

Publications (2)

Publication Number Publication Date
BG110926A BG110926A (bg) 2011-10-31
BG66625B1 true BG66625B1 (bg) 2017-12-15

Family

ID=42288021

Family Applications (1)

Application Number Title Priority Date Filing Date
BG110926A BG66625B1 (bg) 2008-12-22 2009-11-23 Антитуморно лекарство, метод за получаването му и метод за стабилизирането му

Country Status (8)

Country Link
CN (1) CN102227222B (pt)
BG (1) BG66625B1 (pt)
BR (1) BRPI0923273A2 (pt)
EA (1) EA015680B1 (pt)
IL (1) IL213446A (pt)
PL (1) PL219734B1 (pt)
TR (1) TR201104008T1 (pt)
WO (1) WO2010074662A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102784098A (zh) * 2011-05-20 2012-11-21 湖南省湘中制药有限公司 丙戊酸镁注射液及其制备工艺
CN104937096B (zh) * 2013-01-04 2019-11-05 德克萨斯系统大学董事会 包含柠檬酸的组合物及其应用
CN104027301B (zh) * 2013-03-05 2017-05-10 肖云彩 一种奥拉西坦组合物注射液
RU2667128C2 (ru) 2016-12-29 2018-09-14 Герман Петрович Беккер Композиция для приготовления противоопухолевого средства и способ приготовления противоопухолевого средства на ее основе

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534513A (en) * 1991-09-05 1996-07-09 Taiho Pharmaceutical Company, Ltd. Antitumor potentiator and antitumor composition
UA70455A (en) * 2003-09-23 2004-10-15 Serhii Oleksandrovych Shalimov Antineoplastic platinum drug for topical treatmentantineoplastic platinum drug for topical treatment of oropharyngeal cancer and method for its usage of oropharyngeal cancer and method for its usage
UA70456A (en) * 2003-09-23 2004-10-15 Serhii Oleksandrovych Shalimov Dosage form of infusional antineoplastic drug and dosage form of infusional antineoplastic drug and method for its production method for its production

Also Published As

Publication number Publication date
CN102227222B (zh) 2012-11-21
TR201104008T1 (tr) 2011-10-21
BG110926A (bg) 2011-10-31
IL213446A0 (en) 2011-07-31
PL394863A1 (pl) 2011-09-26
PL219734B1 (pl) 2015-07-31
IL213446A (en) 2013-11-28
EA201100618A1 (ru) 2011-10-31
WO2010074662A1 (ru) 2010-07-01
BRPI0923273A2 (pt) 2014-01-28
EA015680B1 (ru) 2011-10-31
CN102227222A (zh) 2011-10-26

Similar Documents

Publication Publication Date Title
EP1595543B1 (en) Antineoplastic pharmaceutical compositions comprising taurolidine or taurultam and 5-fluorouracil
CN101589026B (zh) 治疗脑神经胶质瘤的方法
ES2251134T3 (es) Uso de complejos entre liposomas cationicos y polidesoxirribonucleotidos como medicamentos.
EP2063881B1 (en) A composition and method for the efficacious and safe administration of halopyruvate for the treatment of cancer
JP5919597B2 (ja) デオキシコール酸およびその塩類の製剤
JP2005515202A (ja) プラチナ誘導体の薬学的調合物
JP2015512398A (ja) Ｐｆｋｆｂ２阻害剤および抗癌治療法としての使用方法
US20080311223A1 (en) Injectable polymer-lipid blend for localized drug delivery
BG65827B1 (bg) Фармацевтични разтвори от левосимендан
CN103570766B (zh) 一种新型铂类脂质体制剂及其制备方法
BG66625B1 (bg) Антитуморно лекарство, метод за получаването му и метод за стабилизирането му
KR100644172B1 (ko) 핵산 함유 복합체 제제의 제조 방법
ES2809460T3 (es) Nuevo método de producción de lipoplejo para administración local y fármaco antitumoral que utiliza lipoplejo
US20120302503A1 (en) PEPTIDES FOR PREVENTING OR TREATING A DISEASE OR DISORDER ASSOCIATED WITH CBP OR p300 MISREGULATION, AND METHODS FOR USE AND IDENTIFICATION THEREOF
CN102526038B (zh) 替莫唑胺的脑靶向药物组合物及其应用
JP2016147890A (ja) デオキシコール酸およびその塩類の製剤
CN101732345A (zh) 顺铂脊柱肿瘤缓释植入剂及其制备方法
CN107698639A (zh) 一类吉西他滨磷酸酯的n‑甲酸酯乏氧活化前药及其应用
FI92391C (fi) Menetelmä 3-(N-fenyyliasetyyliaminopiperidiini)-2,6-dionin valmistamiseksi
WO2024034644A1 (ja) 核酸前駆体
CN117731654B (zh) Jjh201601在初发性脑胶质瘤和复发性脑胶质瘤治疗中的新用途
UA90233C2 (uk) Спосіб стабілізації протипухлинних засобів на основі водного розчину сполуки платини з дезоксирибонуклеїновою кислотою
Wampler et al. Antitumor activity of tetraacetylglucosamine mustard
CN112574071A (zh) 一种双胍基连接脂肪碳链的两亲性二甲双胍衍生物及其制药用途
RU2614234C2 (ru) Фармацевтическая композиция на основе 3-(4-Метилимидазол-1-ил)имидазо[1,2-b][1,2,4,5]тетразина в качестве противоопухолевого средства